Immunology and Microbiology
Myasthenia gravis
100%
Monospecific Antibody
39%
Skeletal Muscle
18%
Cholinergic Receptor Antibody
14%
Intravenous Immunoglobulin
14%
Neuromuscular Junction
12%
Lambert-Eaton Myasthenic Syndrome
11%
Muscle Antibody
10%
Allele
10%
Muscle Strength
9%
Forced Vital Capacity
9%
Thymus
8%
Neuromuscular Transmission
7%
Prevalence
6%
Lung Function
5%
ELISA
5%
Muscle Function
5%
Jaw
5%
Mastication
5%
Medicine and Dentistry
Myasthenia gravis
33%
Thymectomy
15%
Disease
11%
Eaton Lambert Syndrome
9%
Immunoglobulin
9%
Glycogen Storage Disease Type II
9%
Placebo
9%
Symptom
8%
Neurology
8%
Small Cell Lung Cancer
7%
Clinical Trial
7%
Muscle Weakness
5%
Prognostic Factor
5%
Enzyme Replacement Therapy
5%
Cholinergic Receptor
5%
Forced Vital Capacity
5%
Muscle Strength
5%
Cholinergic Receptor Antibody
5%
Neuromuscular Disease
5%
Genetic Screening
5%
Jaw
5%
Masticatory Force
5%
Leg
5%
Checklist
5%
Neoplasm
5%
Keyphrases
Myasthenia Gravis
37%
Neuromuscular Disease
15%
Congenital Myasthenic Syndrome
14%
Disease Severity
9%
Clerkship
9%
Mini-clinical Evaluation Exercise (mini-CEX)
9%
Robotic Thymectomy
9%
Acetylcholine Receptor Antibody
9%
Myasthenia
9%
Thymoma
8%
Thymectomy
7%
Dutch
6%
Musk
6%
Acetylcholine Receptor (AChR)
6%
Disability
6%
Neuromuscular Junction
5%
Myasthenic
5%
Indonesian
5%
Disease Impact Profile
5%
ICF Core Set
5%
Disease-related
5%
